Light Horse Therapeutics

Light Horse has developed a proprietary platform that uncovers novel functional sites in disease-critical targets. The company integrated distinct approaches to build this precision genetic editing-based platform that interrogates proteins in their native environment. The company’s technology turns conventional drug discovery on its head by first identifying novel functional domains and then screening for chemistry.